Cilostazol prevents impairment of slow axonal transport in streptozotocin-diabetic rats

By Yamamoto Y.   Yasuda Y.   Komiya Y.  

European Journal of Pharmacology, Vol. 409, Iss. 1, 2000-12 ,pp. : 1-7

Elsevier

Access to resources Recommend Favorite

Nerve function and regeneration in diabetic and galactosaemic rats: antioxidant and metal chelator effects

By Love A.   Cotter M.A.   Cameron N.E.  

European Journal of Pharmacology, Vol. 314, Iss. 1, 1996-10 ,pp. : 33-39

Elsevier

Access to resources Recommend Favorite

Tissue-specific expression of PPAR mRNAs in diabetic rats and divergent effects of cilostazol

By Wang Furong   Gao Ling   Gong Bendi   Hu Jianting   Li Mei   Guan Qingbo   Zhao Jiajun  

Canadian Journal of Physiology and Pharmacology, Vol. 86, Iss. 7, 2008-07 ,pp. : 465-471

NRC Research Press

Access to resources Recommend Favorite

Effects of Cilostazol on Thrombospondin-1 (TSP-1) Expression Changes in the Myocardium of Diabetic Rats

By Ma J   Zheng M   Shen Y   Wang L   Wang L   Zhu Y   Zhang X  

The Journal of International Medical Research, Vol. 36, Iss. 4, 2008-07 ,pp. : 800-809

Field House Publishing

Access to resources Recommend Favorite

PirB is a novel potential therapeutic target for enhancing axonal regeneration and synaptic plasticity following CNS injury in mammals

By Gou Zhaoyu   Mi Yajing   Jiang Fengliang   Deng Bin   Yang Jun   Gou Xingchun  

Journal of Drug Targeting, Vol. 22, Iss. 5, 2014-06 ,pp. : 365-371

Informa Healthcare

Access to resources Recommend Favorite